🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Should Investors Avoid ProAssurance (PRA) Stock Now?

Published 09/24/2017, 10:05 PM
Updated 07/09/2023, 06:31 AM
CACC
-
PRA
-
MKL
-
BFYT
-

ProAssurance Corporation’s (NYSE:PRA) has been suffering from volatility in premium retention, weakening investment portfolio and rising expenses. These headwinds have adversely affected shareholders’ confidence as evident from its price performance. Year to date, its shares have lost 3.4%, underperforming the industry’s gain of nearly 10%.

ProAssurance Corporation Price and Consensus

The company’s physician business has been underperforming due to volatility in premium retention. Increased competition has led to a decline in retention rate since 2011. This continuous loss of insured clients has also been putting pressure on premiums. This severely weighs on the top line.

Deteriorating net investment results has been a headwind for ProAssurance. The company’s net investment results have been deteriorating since 2011. However, the recent interest rate hikes have raised optimism for the company.

ProAssurance has also been facing a rise in underwriting, policy acquisition and operating expenses since 2009. Underwriting expenses started increasing since 2010. This in turn, has been putting pressure on the bottom line.

The stock also seems to be overvalued. Looking at its price-to-book ratio, investors may not agree to pay further premiums. Its trailing 12-month price-to-book ratio of 1.6 is higher than the median of 1.2 of its range and near the highest point of 1.8. It is also pegged slightly higher than the industry average of 1.5.

Zacks Rank and Stocks to Consider

ProAssurance presently has a Zacks Rank #5 (Strong Sell).

Investors interested in the finance sector can consider better-ranked stocks like Markel Corporation (NYSE:MKL) , Health Insurance Innovations, Inc. (NASDAQ:HIIQ) and Credit Acceptance Corporation (NASDAQ:CACC) . While Markel and Health Insurance Innovations sport a Zacks Rank #1 (Strong Buy), Credit Acceptance carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Markel Corporation, the property and casualty insurer, delivered positive surprises in two of the last four quarters with an average of 21.1%.

Health Insurance Innovations, the life insurer, delivered positive surprises in all of the last four quarters with an average of 87.5%.

Credit Acceptance, a consumer loans providing company, delivered positive surprises in the trailing four quarters with an average of 6.7%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Credit Acceptance Corporation (CACC): Free Stock Analysis Report

Health Insurance Innovations, Inc. (HIIQ): Free Stock Analysis Report

ProAssurance Corporation (PRA): Free Stock Analysis Report

Markel Corporation (MKL): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.